DK1227811T3 - Anvendelse af 2-imidazol-substituerede carbinoler til fremstilling af et lægemiddel til behandling eller profylakse af sygdomme fremkaldt af iskæmiske tilstande - Google Patents

Anvendelse af 2-imidazol-substituerede carbinoler til fremstilling af et lægemiddel til behandling eller profylakse af sygdomme fremkaldt af iskæmiske tilstande

Info

Publication number
DK1227811T3
DK1227811T3 DK00972764T DK00972764T DK1227811T3 DK 1227811 T3 DK1227811 T3 DK 1227811T3 DK 00972764 T DK00972764 T DK 00972764T DK 00972764 T DK00972764 T DK 00972764T DK 1227811 T3 DK1227811 T3 DK 1227811T3
Authority
DK
Denmark
Prior art keywords
prophylaxis
imidazole
drug
prepare
treatment
Prior art date
Application number
DK00972764T
Other languages
English (en)
Inventor
Udo Albus
Hans-Willi Jansen
Andreas Weichert
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1227811T3 publication Critical patent/DK1227811T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00972764T 1999-10-27 2000-10-14 Anvendelse af 2-imidazol-substituerede carbinoler til fremstilling af et lægemiddel til behandling eller profylakse af sygdomme fremkaldt af iskæmiske tilstande DK1227811T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951701A DE19951701A1 (de) 1999-10-27 1999-10-27 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
PCT/EP2000/010126 WO2001030327A2 (de) 1999-10-27 2000-10-14 Verwendung von 2-imidazolyl-substituierten carbinolen zur herstellung eines medikaments zur behandlung oder prophylaxe von durch ischämischen zuständen

Publications (1)

Publication Number Publication Date
DK1227811T3 true DK1227811T3 (da) 2004-04-19

Family

ID=7927020

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00972764T DK1227811T3 (da) 1999-10-27 2000-10-14 Anvendelse af 2-imidazol-substituerede carbinoler til fremstilling af et lægemiddel til behandling eller profylakse af sygdomme fremkaldt af iskæmiske tilstande

Country Status (30)

Country Link
US (1) US6291502B1 (da)
EP (1) EP1227811B1 (da)
JP (1) JP2003512419A (da)
KR (1) KR20020060213A (da)
CN (1) CN1188125C (da)
AR (1) AR026241A1 (da)
AT (1) ATE257702T1 (da)
AU (1) AU778836B2 (da)
BR (1) BR0015024A (da)
CA (1) CA2388956A1 (da)
CZ (1) CZ295925B6 (da)
DE (2) DE19951701A1 (da)
DK (1) DK1227811T3 (da)
EE (1) EE200200218A (da)
ES (1) ES2213621T3 (da)
HK (1) HK1048938B (da)
HR (1) HRP20020362A2 (da)
HU (1) HUP0203213A3 (da)
IL (1) IL149208A0 (da)
NO (1) NO20021909L (da)
NZ (1) NZ518586A (da)
PL (1) PL355911A1 (da)
PT (1) PT1227811E (da)
RU (1) RU2257205C2 (da)
SK (1) SK5512002A3 (da)
TR (1) TR200201140T2 (da)
TW (1) TWI246424B (da)
WO (1) WO2001030327A2 (da)
YU (1) YU20902A (da)
ZA (1) ZA200203035B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726829B2 (en) * 1997-04-08 2004-04-27 Scimed Life Systems, Inc. Method of manufacturing a stent
EP1911740B1 (en) * 2002-01-04 2013-02-27 NeuroSearch A/S Potassium channel modulators
US10040767B2 (en) 2014-05-15 2018-08-07 Peloton Therapeutics, Inc. Benzimidazole derivatives and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
US4152441A (en) 1972-02-04 1979-05-01 Gist-Brocades N.V. Analgesic imidazolemethanols
BE794940A (fr) * 1972-02-04 1973-08-02 Gist Brocades Nv Nouveaux composes anorexigenes
US5063220A (en) * 1988-10-21 1991-11-05 Syntex Pharmaceuticals, Ltd. Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6175013B1 (en) * 1994-06-10 2001-01-16 Eli Lilly And Company Imidazolinyl tachykinin receptor antagonists
CA2258165C (en) 1996-06-27 2009-03-03 Marc Gaston Venet N-[4-(heteroarylmethyl)phenyl]-heteroarylamines

Also Published As

Publication number Publication date
AU778836B2 (en) 2004-12-23
YU20902A (sh) 2004-11-25
AR026241A1 (es) 2003-02-05
IL149208A0 (en) 2002-11-10
PL355911A1 (en) 2004-05-31
ATE257702T1 (de) 2004-01-15
BR0015024A (pt) 2002-06-18
HK1048938A1 (en) 2003-04-25
CZ20021452A3 (cs) 2002-07-17
JP2003512419A (ja) 2003-04-02
ES2213621T3 (es) 2004-09-01
CN1188125C (zh) 2005-02-09
WO2001030327A3 (de) 2002-03-14
DE50005040D1 (de) 2004-02-19
HRP20020362A2 (en) 2004-02-29
RU2257205C2 (ru) 2005-07-27
DE19951701A1 (de) 2001-05-03
SK5512002A3 (en) 2002-08-06
EP1227811A2 (de) 2002-08-07
US6291502B1 (en) 2001-09-18
NO20021909D0 (no) 2002-04-23
TWI246424B (en) 2006-01-01
ZA200203035B (en) 2003-03-14
NZ518586A (en) 2004-07-30
KR20020060213A (ko) 2002-07-16
NO20021909L (no) 2002-04-23
HUP0203213A3 (en) 2003-07-28
AU1138201A (en) 2001-05-08
CA2388956A1 (en) 2001-05-03
CZ295925B6 (cs) 2005-11-16
CN1373663A (zh) 2002-10-09
TR200201140T2 (tr) 2002-11-21
WO2001030327A2 (de) 2001-05-03
HK1048938B (zh) 2005-06-10
EE200200218A (et) 2003-06-16
HUP0203213A2 (en) 2003-05-28
PT1227811E (pt) 2004-05-31
EP1227811B1 (de) 2004-01-14
RU2002113666A (ru) 2004-01-10

Similar Documents

Publication Publication Date Title
DK1522314T3 (da) Midler for sygdomme forårsaget af vaskulær sammentrækning eller udvidelse
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1556342T3 (da) Phenethanolaminderivat til behandling af respiratoriske sygdomme
DK1425001T3 (da) Phenethanolaminderivater til behandling af respiratoriske sygdomme
DK1223925T3 (da) Fedtsyrederivat til behandling af eksterne sekretionslidelser
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
NO20031442L (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
ITMI20020756A1 (it) Composizioni farmaceutiche topiche per il trattamento delle dermatiti
FI20011578A0 (fi) Menetelmä puhtaan sitalopraamin valmistamiseksi
CY2009001I1 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
FI20011621A (fi) Menetelmä sitalopraamin valmistamiseksi
NO20035438L (no) Farmasoytisk formulering for effektiv administrering av apomorfin, 6aR-(-)-N-propyl-norapomorfin og deres derivater og prodrugs derav
EE05020B1 (et) Glburiidi ravimkoostis
DK1349580T3 (da) Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning
DK1691607T3 (da) Anvendelse af N-arylhydrazinderivater til bekæmpelse af skadedyr
DK1145696T3 (da) Köretöj til hjælp ved gang
DK1443938T3 (da) Dosisenhed omfattende en prostaglantinanalog til behandling af forstoppelse
DE60017175D1 (de) Ciclesonidhaltige arzneizusammensetzung zur verabreichung auf die schleimhäute
IS7958A (is) Aðferð til að framleiða metýl 2-dífenýlmetýlsúlfínýlasetat
DK1644469T3 (da) Fremgangsmåde til fremstilling af oprensede fedtsyrer
DK1150681T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed
DK1227811T3 (da) Anvendelse af 2-imidazol-substituerede carbinoler til fremstilling af et lægemiddel til behandling eller profylakse af sygdomme fremkaldt af iskæmiske tilstande
DK1503747T3 (da) Diclofenacbaseret sammensætning til topisk behandling af sygdomme
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
DK1282599T3 (da) Disulfidderivater, der er egnede til behandling af allergiske sygdomme